• Deutsch
  • English
  • Contact
  • Events
  • News
  • Downloads
  • Sitemap
  •  
  • Bellevue Group
  • Bank am Bellevue
  • Bellevue Asset Management
  • Investor Relations
  • Services
  • NAV/Performance
  • Investment Products
  • Investment Themes
  • Institutional Mandates
  • Services
  • Legal Information
  • Factsheets
  • KIIDS
  • Video
  • About Us

Disclaimer

To continue, please select your country of domicile and investor type. Depending on your domicile and the investor type that you select, you will have full or restricted access to the products on offer.
 
 
 Save data on this computer

Important

Principles
By using the website www.bellevue.ch, you confirm that you have read, understood and accepted the general information provided by the Bellevue Group as well as these legal provisions. These may be subject to change and the use of the site may be restricted or terminated at any time without prior notice.

No recommendation and/or offer for subscription (or for purchase) and/or redemption (or for sale)
The information, products, data, services, tools and documents contained or described on this site ("website content") are for information purposes only and constitute neither an advertisement or recommendation nor an offer or solicitation (to buy) or redemption (sell) investment instruments, to effect any transaction or to enter into any legal relations.

The financial products mentioned on this site are not suitable for all investors. The information contained on this site does not constitute a financial, legal, fiscal or any other recommendation. Investment or other decisions should not be made solely on the basis of this document. In particular, you should not enter into any investment before you have read the corresponding fund agreement or legal prospectus, the annual and semi-annual reports, the articles of association (as far as they are applicable), as well as all other documents, as required in accordance with local legislation or the regulations applied in the legal jurisdictions or countries in which the corresponding investment fund has been licensed or approved for marketing, offer or sale to the public.

In order to determine whether the investment in shares of a certain investment fund meets your specific requirements and matches your envisaged risks, we recommend that you contact an independent financial adviser. Furthermore, we recommend that you consult an independent tax adviser in order to obtain information on the tax regulations relating to a specific investment in your legal jurisdiction and with regard to your personal circumstances. In particular tax treatment depends on individual circumstances and may be subject to change.

As the funds are recognised (ie. registered) but not authorised in the UK, the UK Financial Services Authority's financial services compensation scheme does not apply to investments in the fund but the Financial Services Authority regulated firm approving this document for the purposes of UK regulation has taken reasonable steps to satisfy itself that Bellevue will deal in an honest and reliable way and is so satisfied.

Performance
Past performance is not an indication or guarantee of the future performance of the investment. The value of investments may be subject to fluctuations and, under certain circumstances, investors may not get back the full amount invested. The performance data are calculated without taking account of commissions and costs that result from subscriptions and redemptions and commissions and costs have a negative impact on performance. Changes in foreign-exchange rates may also cause the value of investments to go up or down.

Target group of the sites
The sites are intended exclusively for use by legal entities and natural persons having their registered office or residing in countries in which the investment funds or the related subfunds or share classes of the Bellevue Group have been properly licensed or approved for public sale, offer or sale in accordance with the applicable local legislation. The funds are currently registered for public distribution in the following countries: Luxembourg, Switzerland, Germany, Austria and the United Kingdom. In all other countries, the funds may, if any, via "Private Placement" according to the local applicable laws.

It is explicitly stated, that alternative fund products are not allowed for public distribution in any country and that they may only and exclusively be solicited to institutional and qualified private investors according to the applicable local laws of each country.

The information and services provided on the sites are not intended for sale to or use by legal entities or natural persons in legal jurisdictions or countries in which the sale or use thereof would violate local legislation or legal provisions, or in which business units forming part of Bellevue Group would be subject to registration requirements in such jurisdictions or countries. Legal entities or natural persons to which such prohibitions apply must not access or use these sites.

The Bellevue funds have NOT been licensed for marketing, offer or sale to the public in the United States in accordance with the US Investment Company Act of 1940 or the US Securities Act of 1933, or in Canada, Japan, Taiwan, Malaysia, Hong Kong or Israel in accordance with the laws in force in those countries. Therefore, particular importance is attached to ensuring that these sites are not intended for legal entities or natural persons, who have their registered office or who reside in such countries, their territories or dependencies or who, on account of their citizenship or similar status, are subject to the law of one of these countries.

Fund documents
All relevant fund documents (namely the prospectus, the Key Investor Information Documents (“KIIDS) and the latest annual and semi-annual reports) may be obtained free of charge from the following address:

Luxembourg: Bellevue Funds (Lux) SICAV, 69, route d'Esch, 1470 Luxembourg

Switzerland: Main sales office, representative and paying agent (for investment funds with Luxembourg and Swiss domicile): Bank am Bellevue AG, Seestrasse 16, 8700 Kusnacht/Zurich

Germany: Paying agent, information and distribution centre in Germany: Bank Julius Bär Europe AG, An der Welle 1, P.O. Box 150252, 60062 Frankfurt am Main

Austria: Paying agent, tax representative and information centre: ERSTE BANK der österreichischen Sparkassen AG, Graben 21, 1010 Vienna

United Kingdom: Facilities agent: Global Funds Registration Limited, 1st Floor, 10 New Street, London EC2M 4TP

Confirmation
By clicking on "Accept", you confirm that you agree to the legal provisions. Alternatively, you can select "I don't accept" if you wish to leave the website.

BB Biotech (Lux) B-USD

ISIN-Nr. LU0415392322 Valoren-Nr. 3882743
  • BB Medtech (Lux)
  • BB Biotech (Lux)
    • BB Biotech Lux B-CHF
    • BB Biotech Lux B-USD
    • BB Biotech Lux B-EUR
    • BB Biotech Lux I-CHF
    • BB Biotech Lux I-USD
    • BB Biotech Lux I-EUR
    • BB Biotech Lux I-EUR
  • BB Entrepreneur Switzerland
  • BB Entrepreneur Europe (Lux)
  • BB Entrepreneur Europe Small (Lux)
  • BB European Opportunities (Lux)
  • BB Entrepreneur Asia (Lux)
  • BB African Opportunities (Lux)
  • BB Silk Road Opportunities (Lux)
  • BB Global Macro (Lux)
  • BB Biotech AG
  • BB Biotech Ventures
  • BB Bioventures
  • Overview
Sorry
We can not provide further information for this product.
© Bellevue Group
  • Disclaimer
  • Newsletter